Pioglitazone, a PPARγ agonist, provides comparable protection to angiotensin converting enzyme inhibitor ramipril against adriamycin nephropathy in rat

Autor: Ochodnicky, Peter, Mesarosova, Lucia, Cernecka, Hana, Klimas, Jan, Krenek, Peter, Goris, Maaike, van Dokkum, Richard P.E., Henning, Robert H., Kyselovic, Jan
Zdroj: In European Journal of Pharmacology 5 May 2014 730:51-60
Databáze: ScienceDirect